Science
Remdesivir is more effective for COVID-19 than standard treatment – The Times Hub
Investing.com – A study by biotech company Gilead Sciences Inc (NASDAQ: GILD) found that a short, 5-day course of treatment of moderately severe hospitalized patients
Investing.com – A study by biotech company Gilead Sciences Inc (NASDAQ: GILD) found that a short, 5-day course of treatment of moderately severe hospitalized patients with COVID-19 with experimental remdesivir was more effective than 10 days and than standard treatment, writes Market Watch.
The results of the third phase of the open-label studies were published in the American scientific journal of the medical association JAMA. The company has already received permission for emergency use of …
-
Noosa News21 hours agoRallies under way as nationwide support for Palestine surges
-
Noosa News22 hours agoHusband charged after beloved Brisbane nurse Carra Luke allegedly stabbed to death in Taigum home
-
General21 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General23 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats